Ipr Drug Patent Portfolio
Ipr owns 1 orange book drug protected by 4 US patents Given below is the list of Ipr's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5466699 | Indolyl compounds for treating migraine | 14 May, 2013 | Expired |
| US5863935 | Therapeutic heterocyclic compounds | 14 May, 2013 | Expired |
| US5466699 | Indolyl compounds for treating migraine | 14 Nov, 2012 | Expired |
| US5863935 | Therapeutic heterocyclic compounds | 14 Nov, 2012 | Expired |
Latest Legal Activities on Ipr's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Ipr.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 08 Nov, 2018 | US7220767 (Litigated) |
|
Request for Trial Denied
Critical
| 02 Feb, 2016 | US7220767 (Litigated) |
|
Request for Trial Denied
Critical
| 27 Jan, 2016 | US6750237 (Litigated) |
|
Recordation of Patent Grant Mailed
Critical
| 22 May, 2007 | US7220767 (Litigated) |
|
Patent Issue Date Used in PTA Calculation
Critical
| 22 May, 2007 | US7220767 (Litigated) |
|
Issue Notification Mailed
Critical
| 02 May, 2007 | US7220767 (Litigated) |
| Dispatch to FDC | 19 Apr, 2007 | US7220767 (Litigated) |
|
Application Is Considered Ready for Issue
Critical
| 18 Apr, 2007 | US7220767 (Litigated) |
|
Issue Fee Payment Received
Critical
| 18 Apr, 2007 | US7220767 (Litigated) |
|
Issue Fee Payment Verified
Critical
| 18 Apr, 2007 | US7220767 (Litigated) |
| Mail Corrected Notice of Allowance | 23 Jan, 2007 | US7220767 (Litigated) |
| Corrected Notice of Allowance | 19 Jan, 2007 | US7220767 (Litigated) |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 31 Jul, 2006 | US6750237 (Litigated) |
|
Correspondence Address Change
Critical
| 31 Jul, 2006 | US6750237 (Litigated) |
|
Mail Notice of Allowance
Critical
| 14 Mar, 2006 | US7220767 (Litigated) |
Ipr's Family Patents
Ipr Drug List
Given below is the complete list of Ipr's drugs and the patents protecting them.
1. Zomig
Zomig is protected by 4 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5466699
(Pediatric)
| Indolyl compounds for treating migraine |
14 May, 2013
(12 years ago)
| Expired |
| US5863935
(Pediatric)
| Therapeutic heterocyclic compounds |
14 May, 2013
(12 years ago)
| Expired |
| US5466699 | Indolyl compounds for treating migraine |
14 Nov, 2012
(12 years ago)
| Expired |
| US5863935 | Therapeutic heterocyclic compounds |
14 Nov, 2012
(12 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zomig's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List